It's worth contemplating also that the wheezo device is one part of the offering. The SaaS part also has value - driving compliance with meds, info about environmental conditions, diarising symptoms to acitivity/conditions etc, analysis of medication use over time. Any age could benefit from this.
A Bright Future Ahead, page-15
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.3¢ |
Change
-0.008(8.79%) |
Mkt cap ! $107.1M | |||
| Open | High | Low | Value | Volume |
| 9.0¢ | 9.3¢ | 8.2¢ | $229.6K | 2.617M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 147500 | 8.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.4¢ | 106500 | 1 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| RSH (ASX) Chart |